Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia

被引：6
|
作者：
Yoshida, Nao [1 ]
Sakaguchi, Hirotoshi [1 ]
Matsumoto, Kimikazu [1 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Dept Haematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 158卷 / 05期
关键词：
gemtuzumab ozogamicin; children; refractory AML; stem cell transplantation; combination chemotherapy; VENOOCCLUSIVE DISEASE; RISK;
D O I：
10.1111/j.1365-2141.2012.09192.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 668
页数：3
相关论文
共 50 条
  • [1] Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?
    Sibson, Keith
    Steward, Colin
    Moppett, John
    Cornish, Jacqueline
    Goulden, Nick
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (03) : 342 - 344
  • [2] Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study
    Zwaan, Christian M.
    Reinhardt, Dirk
    Zimmerman, Martin
    Hasle, Henrik
    Stary, Jan
    Stark, Batia
    Dworzak, Michael
    Creutzig, Ursula
    Kaspers, Gertjan J. L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (05) : 768 - 776
  • [3] Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia
    Cascavilla, Nicola
    D'Arena, Giovanni
    Greco, Michele Mario
    Melillo, Lorella
    Merla, Emanuela
    Carella, Angelo Michele
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (05) : 852 - 853
  • [4] A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia
    Foster, Matthew C.
    Amin, Chirag
    Voorhees, Peter M.
    Van Deventer, Hendrik W.
    Richards, Kristy L.
    Ivanova, Anastasia
    Whitman, Jennifer
    Chiu, Wingkeung Michael
    Barr, Nathan D.
    Shea, Thomas
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1331 - 1337
  • [5] Outcomes Following Hematopoietic Stem Cell Transplantation in Patients Treated With Chemotherapy With or Without Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
    Lambert, J.
    Raffoux, E.
    Chantepie, S.
    Gastaud, L.
    Legrand, O.
    Marolleau, J. -P.
    Pautas, C.
    de Latour, R. Peffault
    Thomas, X.
    Turlure, P.
    Benner, R. J.
    Vandendries, E.
    Gogat, K.
    Dombret, H.
    Castaigne, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 36 - 37
  • [6] Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
    Bono, Roberto
    Sapienza, Giuseppe
    Tringali, Stefania
    Rotolo, Cristina
    Patti, Caterina
    Mule, Antonino
    Calafiore, Valeria
    Santoro, Alessandra
    Castagna, Luca
    CELLS, 2024, 13 (09)
  • [7] Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin
    Capelli, Debora
    Chiarucci, Martina
    Poloni, Antonella
    Saraceni, Francesco
    Mancini, Giorgia
    Trappolini, Silvia
    Troiani, Emanuela
    Montanari, Mauro
    Scortechini, Ilaria
    Offidani, Massimo
    Rupoli, Serena
    Scortechini, Anna Rita
    Gini, Guido
    Discepoli, Giancarlo
    Leoni, Pietro
    Olivieri, Attilio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1399 - 1406
  • [8] Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia
    Pautas, Cecile
    Raffoux, Emmanuel
    Lambert, Juliette
    Legrand, Ollivier
    Chantepie, Sylvain
    Gastaud, Lauris
    Marolleau, Jean-Pierre
    Thomas, Xavier
    Turlure, Pascal
    Benner, Rebecca J.
    Vandendries, Erik
    Gogat, Karin
    Dombret, Herve
    Castaigne, Sylvie
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1474 - 1477
  • [9] Single-dose (4.5 mg/m2) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemia
    Dhunputh, Chloe
    Strullu, Marion
    Petit, Arnaud
    Merched, Maria
    Pasquet, Marlene
    Azarnoush, Saba
    Leverger, Guy
    Ducassou, Stephane
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (02) : 373 - 381
  • [10] Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia
    Eom, Ki-Seong
    Kim, Hee-Je
    Cho, Byung-Sik
    Choi, Su-Mi
    Lee, Dong-Gun
    Lee, Seung-Eun
    Yahng, Seung-Ah
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Park, Chong-Won
    Min, Woo-Sung
    LEUKEMIA & LYMPHOMA, 2011, 52 (12) : 2321 - 2328
12345